The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D050356:Lipid Metabolism; D008134:Long-Term Care; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use*; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects*
D005343:Fibrinolytic Agents; D008696:Methandrostenolone; D010629:Phenformin